Developer docs
API playgroundTry for free, no card

Search company profiles

MediMusic

Full company profile

uuid00045p4

Namestring
MediMusic
Legal namestring
MediMusic
Websiteurl
medimusic.co
Company typeenum
Private
Founded yearint
2017
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHessle, United Kingdom
HQ citystring
Hessle
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics, music therapy platform, AI healthcare solutions, clinical music intervention, pain management software
Industry2 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
NAICS code1 code
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code1 code
  • Services-Health Services8000
Product category
Digital Therapeutics / Music Therapy Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Subscription Service
TypeSubscription Recurring
Description

Monthly per user subscription model for music therapists, providing access to the MediMusic platform, hardware-agnostic solutions including Android & iOS apps, bone conducting headphones, and waterproof headphones for ventilator use

medimusic.co
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure
Pricing details1 tier
1Monthly per user subscription for B2B music therapists
ModelSubscriptionBilling cadenceMonthly
Notes

Hardware agnostic - supplied pre-configured. Android & iOS app included. Bone conducting headphones and waterproof headphones for ventilator use available.

medimusic.co
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

MediMusic operates an AI-driven digital therapeutic platform that uses artificial intelligence and Music Information Retrieval algorithms to analyze audio features (frequency, loudness, tempo, key) and dispense personalized music as medicine to reduce anxiety, pain, cognitive impairment and mental health conditions. The B2B offering for music therapists includes the MediMusic platform, Android and iOS apps, pre-configured bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting with weekly email summaries, and a monthly per-user subscription model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduces anxiety by up to 44%
+3 more records
Product overview1 text field

MediMusic offers a digital therapeutic platform that dispenses music as medicine for anxiety, pain, cognitive impairment, and mental health. The core MediMusic® platform uses AI to analyze music and create personalized playlists based on physiological feedback. The company provides a B2B subscription service for music therapists that includes mobile apps (Android & iOS), pre-configured hardware (bone conducting headphones, waterproof headphones for ventilator use), and weekly email summaries with KPI reporting. The platform is hardware-agnostic and evidence-based, with clinical trials demonstrating effectiveness in reducing anxiety by up to 44%, pain by 29%, and medication use by 24%.

Product and service3 records
1MediMusic® Platform
CategoryDigital Therapeutics Platform
Description

The core digital therapeutic platform that uses artificial intelligence to mimic the human brain's response to music and dispense it as medicine for pain, anxiety, cognitive impairment and mental health. Provides evidence-based, use-case-specific interventions with full KPI reporting and medication cost savings metrics.

2MediMusic Mobile App
CategoryMobile Application
Description

Android and iOS mobile application for delivering music therapy, part of the B2B service for Music Therapists, providing access to the AI-driven personalized playlists and platform features.

3B2B Music Therapists Service
CategoryB2B Subscription Service
Description

Monthly per-user subscription service for music therapists, providing hardware-agnostic solutions with pre-configured devices, Android & iOS apps, bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting and weekly email summaries.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership with Dr. Katherine Finlay from Pain Lab & CINN contributing to evidence-based music therapy research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership with Dr. Ming Hsu specializing in Music Therapy Research based in Cambridge.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital therapeutics company offering evidence-based digital treatments (Sleepio for insomnia, Daylight for anxiety) sold B2B to health systems and employers. Closely comparable to MediMusic as a B2B digital therapeutic targeting anxiety, with NHS and similar health system distribution.

TypeBroad incumbent
Description

Large-scale mental health digital platform combining mindfulness content with therapy services, sold B2B2C through employers and health plans. Comparable to MediMusic in mental health and B2B distribution, but a much broader, content-led incumbent rather than a music-specific therapeutic.

TypeDirect peer
Description

FDA-cleared digital therapeutic company (EndeavorRx) with a focus on evidence-based software as medicine, sold via healthcare providers and payers. Directly comparable to MediMusic as a clinically validated digital therapeutic targeting specific conditions.

TypeDirect peer
Description

Digital therapeutics company developing prescription software for indications such as depression and migraine, often via pharma partnerships. Comparable as a prescription-grade digital therapeutic with B2B payer/provider distribution.

5LUCID (Music Therapy Platform)
TypeEmerging player
Description

Music therapy digital platform targeting healthcare settings with curated therapeutic playlists. Closely comparable to MediMusic in the music-as-medicine niche, though a smaller and less clinically evidenced player.

TypeEmerging player
Description

UK-based AI mental health platform providing digital self-referral and triage tools for NHS IAPT services. Comparable to MediMusic as a UK AI mental health B2B platform selling into NHS pathways, though with a different therapeutic modality.

7Pear Therapeutics
TypeDirect peer
Description

Pioneer in prescription digital therapeutics (reSET, reSET-O, Somryst) for substance use disorder and insomnia before its wind-down. Highly comparable as a regulatory-grade digital therapeutic business model, though now operates as a restructured entity.

TypeEmerging player
Description

Digital therapeutics platform using music and other behavioral interventions to support patient wellness and recovery, sold to hospitals and health systems. Comparable to MediMusic in combining music with clinical outcomes measurement in B2B healthcare.

TypeBroad incumbent
Description

AI-driven mental health chatbot platform sold to employers and health systems including NHS. Comparable to MediMusic as a B2B digital mental health solution targeting NHS and large employers, though via conversational AI rather than music.

TypeRegional player
Description

UK and Europe-based digital health provider offering online consultations and digital therapeutic services. Comparable to MediMusic as a UK-headquartered digital health B2B/B2C player navigating NHS and European healthcare regulation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MediMusic

Digital Therapeutics / Music Therapy Softwaremedimusic.co

MediMusic firmographics

Firmographics
Name
MediMusic
Legal name
MediMusic
Website
https://medimusic.co
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

MediMusic industry classification

Industry
Product category
Digital Therapeutics / Music Therapy Software
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms

Keywords

  • Digital therapeutics
  • Music therapy platform
  • AI healthcare solutions
  • Clinical music intervention
  • Pain management software

Where MediMusic is headquartered

Location

Headquarters

HQ city
Hessle
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

MediMusic business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure

Revenue model

  1. B2B Subscription Service: Monthly per user subscription model for music therapists, providing access to the MediMusic platform, hardware-agnostic solutions including Android & iOS apps, bone conducting headphones, and waterproof headphones for ventilator use

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyMonthly per user subscription for B2B music therapists

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

MediMusic product offering

Product offering

Core offering

MediMusic operates an AI-driven digital therapeutic platform that uses artificial intelligence and Music Information Retrieval algorithms to analyze audio features (frequency, loudness, tempo, key) and dispense personalized music as medicine to reduce anxiety, pain, cognitive impairment and mental health conditions. The B2B offering for music therapists includes the MediMusic platform, Android and iOS apps, pre-configured bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting with weekly email summaries, and a monthly per-user subscription model.

Product overview

MediMusic offers a digital therapeutic platform that dispenses music as medicine for anxiety, pain, cognitive impairment, and mental health. The core MediMusic® platform uses AI to analyze music and create personalized playlists based on physiological feedback. The company provides a B2B subscription service for music therapists that includes mobile apps (Android & iOS), pre-configured hardware (bone conducting headphones, waterproof headphones for ventilator use), and weekly email summaries with KPI reporting. The platform is hardware-agnostic and evidence-based, with clinical trials demonstrating effectiveness in reducing anxiety by up to 44%, pain by 29%, and medication use by 24%.

Differentiator

Problem solved

Functional benefit

Products and services

  • MediMusic® Platform The core digital therapeutic platform that uses artificial intelligence to mimic the human brain's response to music and dispense it as medicine for pain, anxiety, cognitive impairment and mental health. Provides evidence-based, use-case-specific interventions with full KPI reporting and medication cost savings metrics.
  • MediMusic Mobile App Android and iOS mobile application for delivering music therapy, part of the B2B service for Music Therapists, providing access to the AI-driven personalized playlists and platform features.
  • B2B Music Therapists Service Monthly per-user subscription service for music therapists, providing hardware-agnostic solutions with pre-configured devices, Android & iOS apps, bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting and weekly email summaries.

Quantifiable outcome

  • Reduces anxiety by up to 44%
  • +3 more outcomes

Companies that use MediMusic

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

MediMusic technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

MediMusic partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • University of ReadingcoreStrategic or Co-development PartnerAcademic research partnership with Dr. Katherine Finlay from Pain Lab & CINN contributing to evidence-based music therapy research.
  • Anglia Ruskin UniversitycoreStrategic or Co-development PartnerAcademic partnership with Dr. Ming Hsu specializing in Music Therapy Research based in Cambridge.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

MediMusic competitors and assessment

Company assessment

Direct peers

  • Big Health: Digital therapeutics company offering evidence-based digital treatments (Sleepio for insomnia, Daylight for anxiety) sold B2B to health systems and employers. Closely comparable to MediMusic as a B2B digital therapeutic targeting anxiety, with NHS and similar health system distribution.
  • Akili Interactive: FDA-cleared digital therapeutic company (EndeavorRx) with a focus on evidence-based software as medicine, sold via healthcare providers and payers. Directly comparable to MediMusic as a clinically validated digital therapeutic targeting specific conditions.
  • Click Therapeutics: Digital therapeutics company developing prescription software for indications such as depression and migraine, often via pharma partnerships. Comparable as a prescription-grade digital therapeutic with B2B payer/provider distribution.
  • Pear Therapeutics: Pioneer in prescription digital therapeutics (reSET, reSET-O, Somryst) for substance use disorder and insomnia before its wind-down. Highly comparable as a regulatory-grade digital therapeutic business model, though now operates as a restructured entity.

Broad incumbents

  • Headspace Health: Large-scale mental health digital platform combining mindfulness content with therapy services, sold B2B2C through employers and health plans. Comparable to MediMusic in mental health and B2B distribution, but a much broader, content-led incumbent rather than a music-specific therapeutic.
  • Wysa: AI-driven mental health chatbot platform sold to employers and health systems including NHS. Comparable to MediMusic as a B2B digital mental health solution targeting NHS and large employers, though via conversational AI rather than music.

Emerging players

  • LUCID (Music Therapy Platform): Music therapy digital platform targeting healthcare settings with curated therapeutic playlists. Closely comparable to MediMusic in the music-as-medicine niche, though a smaller and less clinically evidenced player.
  • Limbic: UK-based AI mental health platform providing digital self-referral and triage tools for NHS IAPT services. Comparable to MediMusic as a UK AI mental health B2B platform selling into NHS pathways, though with a different therapeutic modality.
  • Wellbeat: Digital therapeutics platform using music and other behavioral interventions to support patient wellness and recovery, sold to hospitals and health systems. Comparable to MediMusic in combining music with clinical outcomes measurement in B2B healthcare.

Regional players

  • Zava: UK and Europe-based digital health provider offering online consultations and digital therapeutic services. Comparable to MediMusic as a UK-headquartered digital health B2B/B2C player navigating NHS and European healthcare regulation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MediMusic social profiles

Digital presence

MediMusic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MediMusic leadership team

Management profile

Number of profiles

Profiles13 records

MediMusic funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MediMusic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediMusic

What does MediMusic do?

MediMusic operates an AI-driven digital therapeutic platform that uses artificial intelligence and Music Information Retrieval algorithms to analyze audio features (frequency, loudness, tempo, key) and dispense personalized music as medicine to reduce anxiety, pain, cognitive impairment and mental health conditions. The B2B offering for music therapists includes the MediMusic platform, Android and iOS apps, pre-configured bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting with weekly email summaries, and a monthly per-user subscription model.

Is MediMusic a public or private company?

MediMusic is a private company. It is classified as venture growth investor backed and is currently operating.

When was MediMusic founded?

MediMusic was founded in 2017. It employs 1 to 10 people.

Where is MediMusic based?

MediMusic is headquartered in Hessle, United Kingdom, in the Europe region.

How does MediMusic make money?

One revenue line is on record: B2B Subscription Service.

Who are MediMusic's main competitors?

Direct peers on record are Big Health, Akili Interactive, Click Therapeutics and Pear Therapeutics. Broad incumbents are Headspace Health and Wysa. Emerging players are LUCID (Music Therapy Platform), Limbic and Wellbeat. Zava is listed as a regional player.

Does MediMusic have an API?

No public API is recorded for MediMusic.

What industry is MediMusic in?

MediMusic's product category is Digital Therapeutics / Music Therapy Software. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621420 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMusic Therapy Market to Surpass USD 6.03 Billion by 2033, Expanding at 9.4% CAGR | 2026-2033 Forecast |MedRhythms, Inc., MediMusic, VibroAcousticsCoherent Market Insights released a forecast projecting the global music therapy market will grow from USD 3.22 billion in 2026 to USD 6.03 billion by 2033, at a compound annual growth rate of 9.4%. The report profiles key industry participants including MedRhythms Inc., MediMusic, and VibroAcoustics while analyzing regional trends and application segments such as mental health and neurological rehabilitation. This analysis provides strategic insights into market drivers, competitive landscapes, and investment opportunities for stakeholders.openPR.comIncredible Growth of Music Therapy Market Trends, Innovations & Opportunities By 2023| MedRhythms, Inc., MediMusic, VibroAcousticsThe article discusses the growth prospects of the Music Therapy Market, supported by rapid innovation, rising investment, and regional shifts, with forecasts extending from 2026 to 2033. It provides insights into market segmentation, key players, and regional coverage, highlighting opportunities and strategic considerations.ForbesThe Mental Health Remix: Can MusicTech Help Us Feel Better?Music-tech companies are using AI and neuroscience to treat anxiety, pain, and cognitive impairment, with MediMusic and Spiritune leading. MediMusic's Digital Drip system dynamically generates music to reduce cortisol and improve heart rate variability, while Spiritune reported a 60% improvement in mental health scores in three weeks. The industry aims to integrate music therapy into clinical care.SteelfmMusic treatment pioneer MediMusic teams up with university researchers to help South Asian patients – Steel FM ScunthorpeHull-based healthtech company MediMusic has secured over £183,000 in funding from Innovate UK to collaborate with Anglia Ruskin University researchers on developing AI-driven music therapy for South Asian dementia patients. The project aims to utilize machine learning to create personalized playlists via the MediBeat device, building on initial trials that demonstrated a 25% reduction in patient heart rates.Business LiveMusic treatment pioneer MediMusic teams up with university researchers to help South Asian patientsMediMusic, a Hull-based healthtech company, received over £183,000 from Innovate UK to research AI and music therapy for South Asian dementia patients. The project, led by founder Gary Jones, aims to reduce anxiety and pain, with initial trials showing up to 25% heart rate reduction. A controlled pilot study with care home residents is planned.CelebrityAccessMediMusic Wins Music Tech Startup Award: AI Transforms HealthcareMediMusic won the Music Tech Start-Up Award at the Wallifornia Accelerator and Summit 2024. Its AI-generated playlists for dementia patients reduced heart rate by 25% in UK trials. The company plans to expand trials to more hospitals and care homes in the UK and US.BusinessCloudWarner & UK HealthTech trial ‘music as medicine’Warner Music Group partnered with MediMusic to trial music therapy for pain, anxiety, and stress in US and UK hospitals and care homes. Initial UK NHS trials on dementia patients reduced heart rate by 25%, and MediMusic claims it could slash medication bills by up to a quarter.Yorkshire PostHull MedTech start-up secures £1.2m to scale-up 'music as medicine' innovationHull-based MediMusic secured £1.2 million in investment to scale its AI-driven 'music as medicine' technology for patient care. The funding, which includes £200,000 from Finance Yorkshire and contributions from the University of Hull and private investors, supports the expansion of the MediBeat app and streaming device following successful NHS clinical trials.BBCTech Tent: Is AI music the best medicine?MediMusic, a Hull-based startup, uses AI to generate personalized playlists that reduce anxiety and pain. Trials in Lancashire hospitals showed up to 22% heart rate reduction and potential NHS medication savings of up to a quarter. The company claims its system could be prescribed to patients and stressed medical staff.HULL IS THISRevolutionary new app dispenses music as medicine to reduce anxiety and pain in patients and NHS staffMediMusic is launching an NHS trial of its music therapy app for 40 critical care staff, with initial dementia trials showing a 22% heart rate reduction. The app uses AI to create personalized playlists, potentially reducing medication use by up to 25%.